FR2391198B1 - - Google Patents

Info

Publication number
FR2391198B1
FR2391198B1 FR7814730A FR7814730A FR2391198B1 FR 2391198 B1 FR2391198 B1 FR 2391198B1 FR 7814730 A FR7814730 A FR 7814730A FR 7814730 A FR7814730 A FR 7814730A FR 2391198 B1 FR2391198 B1 FR 2391198B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7814730A
Other versions
FR2391198A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Publication of FR2391198A1 publication Critical patent/FR2391198A1/fr
Application granted granted Critical
Publication of FR2391198B1 publication Critical patent/FR2391198B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7814730A 1977-05-18 1978-05-18 Produit hygienique a jeter apres usage Granted FR2391198A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5631077A JPS53149926A (en) 1977-05-18 1977-05-18 Methylmethionine sulfonium derivative

Publications (2)

Publication Number Publication Date
FR2391198A1 FR2391198A1 (fr) 1978-12-15
FR2391198B1 true FR2391198B1 (fr) 1981-07-31

Family

ID=13023563

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7814730A Granted FR2391198A1 (fr) 1977-05-18 1978-05-18 Produit hygienique a jeter apres usage

Country Status (8)

Country Link
US (1) US4216225A (fr)
JP (1) JPS53149926A (fr)
DE (1) DE2821704A1 (fr)
ES (2) ES469926A1 (fr)
FR (1) FR2391198A1 (fr)
GB (1) GB1596884A (fr)
IT (1) IT1096355B (fr)
SE (1) SE7805642L (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2915480A1 (de) * 1979-04-17 1980-10-30 Kaken Chemical Co Hypolipidaemie-mittel
US4440788A (en) * 1980-05-13 1984-04-03 Mitsubishi Chemical Industries, Limited Cysteine derivatives
FR2503151A1 (fr) * 1981-04-02 1982-10-08 Morelle Jean Butyryminoacides soufres. mode de preparation. emploi comme element keratogenique chez l'homme et l'animal et comme agent de fertilisation chez les vegetaux
JPS63302851A (ja) * 1987-06-02 1988-12-09 Nippon Medical Supply Corp 血小板保存用血液バッグ
US5053429A (en) * 1988-04-08 1991-10-01 The Lithox Corporation, Inc. Treating inflammatory pain with methionine
JPH0620523Y2 (ja) * 1989-12-07 1994-06-01 川澄化学工業株式会社 医療用容器
US5292773A (en) * 1990-02-14 1994-03-08 Hirsch Gerald P Treating aids and HIV infection with methionine
US5084482A (en) * 1990-04-10 1992-01-28 The Lithox Corporation Methods for inhibiting inflammatory ischemic, thrombotic and cholesterolemic disease response with methionine compounds
US20050169704A1 (en) * 2004-01-16 2005-08-04 Alan Vu Mortise and tenon joint
MY159355A (en) * 2008-11-19 2016-12-30 Pola Chem Ind Inc Anti-wrinkle agents
BR112023011898A2 (pt) * 2021-07-20 2024-03-05 Lier Chemical Co Ltd Método de preparação para glufosinato
CN115043765B (zh) * 2022-06-07 2023-08-15 黑龙江八一农垦大学 一种甲硫氨酸衍生物和其盐类的制备及作为基因载体的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6514139A (fr) 1964-11-02 1966-05-03

Also Published As

Publication number Publication date
ES473440A1 (es) 1979-06-01
DE2821704A1 (de) 1978-11-23
SE7805642L (sv) 1978-11-19
FR2391198A1 (fr) 1978-12-15
JPS53149926A (en) 1978-12-27
JPS6126538B2 (fr) 1986-06-20
IT7823561A0 (it) 1978-05-18
ES469926A1 (es) 1978-12-16
IT1096355B (it) 1985-08-26
US4216225A (en) 1980-08-05
GB1596884A (en) 1981-09-03

Similar Documents

Publication Publication Date Title
FR2377568B1 (fr)
FR2376881B1 (fr)
FR2391198B1 (fr)
FR2377591B1 (fr)
FR2378252B1 (fr)
FR2378365B1 (fr)
FR2378174B1 (fr)
FR2378315B1 (fr)
BG25845A1 (fr)
BG25822A1 (fr)
BG25848A1 (fr)
BG25847A1 (fr)
BG25810A1 (fr)
BG25844A1 (fr)
BG25841A1 (fr)
BG25809A1 (fr)
BG25839A1 (fr)
BG25838A1 (fr)
BG25851A1 (fr)
BG25837A1 (fr)
BG25834A1 (fr)
BG25829A1 (fr)
BG25828A1 (fr)
BG25827A2 (fr)
BG25826A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse